Discussing COVID-19 Vaccines in Private Facebook Groups
Status
Conditions
Treatments
Details and patient eligibility
About
As the COVID-19 pandemic persists, a sizable proportion of the U.S. population remains unvaccinated and at high risk of death and serious illness from COVID-19. Vaccine hesitancy, fueled by the proliferation of vaccine misinformation on social media, is one factor contributing to lack of vaccination. Current attempts to overcome vaccine misinformation focus on correcting or debunking falsehoods. Although debunking strategies are important components to any public health campaign, communications must also address rationales for vaccine hesitancy that vary among individuals and communities, and directly address the gist of their concerns in an empathetic, non-judgmental manner. We will conduct a randomized controlled trial to test the effectiveness of empathic, relationship-building interactions relative to standard provision of information on social media to address COVID-19 vaccine hesitancy.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- reside in the U.S.
- unvaccinated from COVID-19
- Use Facebook regularly (at least 1/day)
Exclusion criteria
- age <18 years
- do not reside in the U.S.
- vaccinated from COVID-19
- do not use Facebook regularly (at least 1/day)
Trial design
Primary purpose
Allocation
Interventional model
Masking
508 participants in 2 patient groups, including a placebo group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal